Acrivon Therapeutics Inc
Research Acrivon Therapeutics Inc (ACRV) on Bullrun: market cap USD 76.19M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerACRV
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 76.19M
- Financial periodFY2025
- Net income-USD 77.91M
- Free cash flow-USD 65.33M
Valuation Snapshot
latest market cap is USD 76.19M.
About Acrivon Therapeutics Inc
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates.
Frequently asked questions
What is Acrivon Therapeutics Inc's market cap?
Acrivon Therapeutics Inc's market capitalization is USD 76.19M.
What does Acrivon Therapeutics Inc do?
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.